COWEN AND COMPANY, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,334,000
+18.3%
87,132
+7.9%
0.13%
+18.5%
Q1 2022$1,128,000
+1609.1%
80,750
+100.9%
0.11%
+1700.0%
Q4 2021$66,000
-84.4%
40,200
-71.3%
0.01%
-72.7%
Q2 2021$424,000
+100.9%
140,151
+209.4%
0.02%
+57.1%
Q1 2021$211,000
+137.1%
45,300
+126.5%
0.01%
+75.0%
Q4 2020$89,000
+107.0%
20,000
+100.0%
0.01%
+100.0%
Q4 2019$43,000
-95.9%
10,000
-85.5%
0.00%
-98.5%
Q3 2019$1,042,00069,0520.26%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders